BridgeBio Pharma (BBIO) stock valuation

$78.01 Nov 18, 2026 · market cap $14.9B

11/121 investors
i

BridgeBio Pharma trades at $78. We don't have a valuation for it yet.

11 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate BBIOCreate your account →

Full open-source research report for BBIO on DeepValues Research (CC BY 4.0)